Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of TDRD9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2196.58 | 652 / 653 | 64% | 5.59 | 389 / 605 |
brain | 89% | 395.33 | 2348 / 2642 | 49% | 1.48 | 347 / 705 |
kidney | 91% | 337.42 | 81 / 89 | 33% | 2.30 | 294 / 901 |
adrenal gland | 60% | 151.70 | 155 / 258 | 57% | 2.45 | 132 / 230 |
lung | 85% | 334.38 | 494 / 578 | 18% | 1.57 | 203 / 1155 |
spleen | 95% | 888.10 | 230 / 241 | 0% | 0 | 0 / 0 |
pancreas | 46% | 82.85 | 152 / 328 | 37% | 1.27 | 65 / 178 |
breast | 61% | 120.81 | 278 / 459 | 20% | 1.95 | 222 / 1118 |
peripheral blood | 73% | 1503.92 | 677 / 929 | 0% | 0 | 0 / 0 |
stomach | 62% | 130.83 | 223 / 359 | 10% | 0.83 | 28 / 286 |
heart | 71% | 210.44 | 609 / 861 | 0% | 0 | 0 / 0 |
bladder | 57% | 91.48 | 12 / 21 | 9% | 0.93 | 47 / 504 |
uterus | 36% | 63.28 | 62 / 170 | 21% | 5.68 | 97 / 459 |
esophagus | 49% | 106.56 | 714 / 1445 | 8% | 0.50 | 14 / 183 |
prostate | 47% | 87.01 | 114 / 245 | 10% | 0.34 | 52 / 502 |
skin | 14% | 22.76 | 252 / 1809 | 38% | 7.46 | 181 / 472 |
intestine | 44% | 80.21 | 427 / 966 | 6% | 0.27 | 32 / 527 |
ovary | 24% | 45.14 | 43 / 180 | 21% | 2.66 | 92 / 430 |
adipose | 44% | 85.28 | 533 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 38% | 8.53 | 17 / 45 |
lymph node | 0% | 0 | 0 / 0 | 31% | 0.78 | 9 / 29 |
blood vessel | 30% | 50.89 | 400 / 1335 | 0% | 0 | 0 / 0 |
liver | 13% | 20.68 | 29 / 226 | 4% | 0.55 | 15 / 406 |
eye | 0% | 0 | 0 / 0 | 4% | 0.18 | 3 / 80 |
muscle | 1% | 2.14 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0034587 | Biological process | piRNA processing |
GO_0009566 | Biological process | fertilization |
GO_0007283 | Biological process | spermatogenesis |
GO_0141006 | Biological process | piRNA-mediated retrotransposon silencing by heterochromatin formation |
GO_0007141 | Biological process | male meiosis I |
GO_0030154 | Biological process | cell differentiation |
GO_0007140 | Biological process | male meiotic nuclear division |
GO_0141007 | Biological process | siRNA-mediated retrotransposon silencing by heterochromatin formation |
GO_0005622 | Cellular component | intracellular anatomical structure |
GO_0071547 | Cellular component | piP-body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004386 | Molecular function | helicase activity |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | TDRD9 |
Protein name | Tudor domain containing 9 ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9) |
Synonyms | C14orf75 |
Description | FUNCTION: ATP-binding RNA helicase required during spermatogenesis . Required to repress transposable elements and prevent their mobilization, which is essential for the germline integrity. Acts via the piRNA metabolic process, which mediates the repression of transposable elements during meiosis by forming complexes composed of piRNAs and Piwi proteins and governs the methylation and subsequent repression of transposons. Acts downstream of piRNA biogenesis: exclusively required for transposon silencing in the nucleus, suggesting that it acts as a nuclear effector in the nucleus together with PIWIL4. . |
Accessions | H0YJJ2 ENST00000409874.9 [Q8NDG6-1] ENST00000557332.5 Q8NDG6 |